Skip to main content
PHVS logo

Pharvaris N.V.

PHVSNASDAQHealthcareBiotechnology

$31.54Today:- (-)1Y +33.09%

As of Oct 26, 2026 close

Market cap
$2.15B
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$21.02$43.25
Volume (live)
-
Avg. volume (3M)
721.13K

Pharvaris (PHVS) Income Statement

In fiscal 2025 (fiscal year ended Mar 31, 2026), Pharvaris posted a net loss of EUR 175.70M, compared with a net loss of EUR 134.22M a year earlier.

Pharvaris Income Statement Analysis

Values in millions EUR

Scroll to see more
Pharvaris N.V. income statement - Annual data in millions EUR
BreakdownFY 2025FY 2025FY 2024FY 2024FY 2023FY 2023FY 2022FY 2022FY 2021FY 2020FY 2020FY 2019FY 2018
Period endingMar 2026Dec 2025Mar 2025Dec 2024Mar 2024Dec 2023Mar 2023Dec 2022Dec 2021Mar 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue0.00-0.00-0.00-0.00-0.000.00-0.000.00
Cost of Revenue0.00-0.00-0.00-0.00-0.00---0.00
Gross Profit0.00-0.00-0.00-0.00-0.00---0.00
Operating Expenses
Research & Development124.48124.4898.5698.5665.5865.5857.3857.3835.7922.2419.516.363.65
Selling, General & Administrative45.3445.3447.1247.1231.3431.3429.3429.3418.356.265.502.600.67
Operating Expenses169.82169.82145.69145.6996.9196.9186.7186.7154.1428.5025.018.964.31
Operating Income-169.82-169.82-145.69-145.69-96.91-96.91-86.71-86.71-54.14-28.51-25.01-8.97-4.31
Other Income/Expense
Interest Income0.00-3.895.4713.290.00-2.91-11.06----0.00
Interest Expense0.00-0.00-0.00-0.020.02-0.270.09-0.090.000.00
Other Income/Expense-3.89-3.8913.297.87-2.91-3.1211.0611.1011.48-1.21-0.01-0.020.00
Income
Income Before Tax-173.71-173.71-132.40-132.40-99.83-99.83-75.65-75.65-42.66-29.72-26.07-8.98-4.31
Income Tax Expense1.991.991.831.831.051.050.680.680.07-0.09-0.080.000.00
Net Income-175.70-175.70-134.22-134.22-100.88-100.88-76.33-76.33-42.73-29.62-25.99-8.98-4.31
Net Income - Continuous Operations-175.70-175.70-134.22-134.22-100.88-100.88-76.33-76.33-42.73-29.62--8.98-4.31
Net Income - Discontinued Operations-------------
EBITDA-173.29-169.63-145.59-145.42-99.57-96.66-86.56-86.56-54.06-29.71-25.00-8.98-4.31
EBIT--169.82--145.69--96.91--86.71-54.14--25.01--
Depreciation & Amortization0.420.420.100.270.260.260.150.150.08-0.01-4.31
Earnings Per Share
Basic EPS-3.00-3.00-2.00-2.00-3.00-3.00-2.00-2.00-1.00-1.00-5.00--
Diluted EPS-3.00-3.00-2.00-2.00-3.00-3.00-2.00-2.00-1.00-1.00-5.00--
Basic Shares Outstanding59.1659.1654.0254.0238.3938.3933.5933.5930.4130.524.8531.8431.84
Diluted Shares Outstanding59.1659.1654.0254.0238.3938.3933.5933.5930.4130.524.8531.8431.84

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Pharvaris Financial Statements

Is Pharvaris profitable?

No. Pharvaris reported a net loss of EUR 175.70M in fiscal 2025. In fiscal 2024 it lost EUR 134.22M.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition